195 related articles for article (PubMed ID: 15705582)
41. The effect of cotinine or cigarette smoke co-administration on the formation of O6-methylguanine adducts in the lung and liver of A/J mice treated with 4-(methylnitrosamino)-1-(3-pyridyl)-1-butanone (NNK).
Brown BG; Chang CJ; Ayres PH; Lee CK; Doolittle DJ
Toxicol Sci; 1999 Jan; 47(1):33-9. PubMed ID: 10048151
[TBL] [Abstract][Full Text] [Related]
42. The tobacco-specific carcinogen NNK induces pulmonary tumorigenesis via nAChR/Src/STAT3-mediated activation of the renin-angiotensin system and IGF-1R signaling.
Boo HJ; Min HY; Hwang SJ; Lee HJ; Lee JW; Oh SR; Park CS; Park JS; Lee YM; Lee HY
Exp Mol Med; 2023 Jun; 55(6):1131-1144. PubMed ID: 37258578
[TBL] [Abstract][Full Text] [Related]
43. Apigenin inhibits NNK-induced focal adhesion kinase activation in pancreatic cancer cells.
Pham H; Chen M; Takahashi H; King J; Reber HA; Hines OJ; Pandol S; Eibl G
Pancreas; 2012 Nov; 41(8):1306-15. PubMed ID: 22889981
[TBL] [Abstract][Full Text] [Related]
44. 4-(Methylnitrosamino)-1-(3-pyridyl)-1-butanone (NNK) enhances invasiveness of lung cancer cells by up-regulating contactin-1 via the alpha7 nicotinic acetylcholine receptor/ERK signaling pathway.
Hung YH; Hung WC
Chem Biol Interact; 2009 May; 179(2-3):154-9. PubMed ID: 19027725
[TBL] [Abstract][Full Text] [Related]
45. The Proto-oncogene PKCι regulates the alternative splicing of Bcl-x pre-mRNA.
Shultz JC; Vu N; Shultz MD; Mba MU; Shapiro BA; Chalfant CE
Mol Cancer Res; 2012 May; 10(5):660-9. PubMed ID: 22522453
[TBL] [Abstract][Full Text] [Related]
46. Effect of phenethyl isothiocyanate on the metabolism of the tobacco-specific nitrosamine 4-(methylnitrosamino)-1-(3-pyridyl)-1-butanone by cultured rat lung tissue.
Doerr-O'Rourke K; Trushin N; Hecht SS; Stoner GD
Carcinogenesis; 1991 Jun; 12(6):1029-34. PubMed ID: 2044181
[TBL] [Abstract][Full Text] [Related]
47. Protein kinase C
Kenchappa RS; Liu Y; Argenziano MG; Banu MA; Mladek AC; West R; Luu A; Quiñones-Hinojosa A; Hambardzumyan D; Justilien V; Leitges M; Sarkaria JN; Sims PA; Canoll P; Murray NR; Fields AP; Rosenfeld SS
Cell Rep; 2021 Nov; 37(8):110054. PubMed ID: 34818553
[TBL] [Abstract][Full Text] [Related]
48. A small molecule inhibitor of atypical protein kinase C signaling inhibits pancreatic cancer cell transformed growth and invasion.
Butler AM; Scotti Buzhardt ML; Erdogan E; Li S; Inman KS; Fields AP; Murray NR
Oncotarget; 2015 Jun; 6(17):15297-310. PubMed ID: 25915428
[TBL] [Abstract][Full Text] [Related]
49. γ-H2AX is a sensitive marker of DNA damage induced by metabolically activated 4-(methylnitrosamino)-1-(3-pyridyl)-1-butanone.
Ibuki Y; Shikata M; Toyooka T
Toxicol In Vitro; 2015 Oct; 29(7):1831-8. PubMed ID: 26231820
[TBL] [Abstract][Full Text] [Related]
50. Enzymes involved in the bioactivation of 4-(methylnitrosamino)-1-(3-pyridyl)-1-butanone in patas monkey lung and liver microsomes.
Smith TJ; Liao AM; Liu Y; Jones AB; Anderson LM; Yang CS
Carcinogenesis; 1997 Aug; 18(8):1577-84. PubMed ID: 9276633
[TBL] [Abstract][Full Text] [Related]
51. Metabolism and DNA damage induced by 4-(methylnitrosamino)-1-(3-pyridyl)-1-butanone in fetal tissues of the Syrian golden hamster.
Rossignol G; Alaoui-Jamali MA; Castonguay A; Schuller HM
Cancer Res; 1989 Oct; 49(20):5671-6. PubMed ID: 2790785
[TBL] [Abstract][Full Text] [Related]
52. Comparative metabolism of the tobacco-specific nitrosamines 4-(methylnitrosamino)-1-(3-pyridyl)-1-butanone and 4-(methylnitrosamino)-1-(3-pyridyl)-1-butanol by rat cytochrome P450 2A3 and human cytochrome P450 2A13.
Jalas JR; Ding X; Murphy SE
Drug Metab Dispos; 2003 Oct; 31(10):1199-202. PubMed ID: 12975327
[TBL] [Abstract][Full Text] [Related]
53. Carbonyl reduction of the tobacco-specific nitrosamine 4-(methylnitrosamino)-1-(3-pyridyl)-1-butanone (NNK) in cytosol of mouse liver and lung.
Atalla A; Maser E
Toxicology; 1999 Nov; 139(1-2):155-66. PubMed ID: 10614696
[TBL] [Abstract][Full Text] [Related]
54. Analysis of human urine for pyridine-N-oxide metabolites of 4-(methylnitrosamino)-1-(3-pyridyl)-1-butanone, a tobacco-specific lung carcinogen.
Carmella SG; Borukhova A; Akerkar SA; Hecht SS
Cancer Epidemiol Biomarkers Prev; 1997 Feb; 6(2):113-20. PubMed ID: 9037562
[TBL] [Abstract][Full Text] [Related]
55. The oncogenic role of PKCiota gene amplification and overexpression in Chinese non-small cell lung cancer.
Luo Q; Tang L; Lin H; Huang J; Zhang T; Liu Y; Wang J; Zhan P; Yin X; Su X; Ji Q; Yu D; Xu L
Lung Cancer; 2014 May; 84(2):190-5. PubMed ID: 24636699
[TBL] [Abstract][Full Text] [Related]
56. Targeting atypical protein kinase C iota reduces viability in glioblastoma stem-like cells via a notch signaling mechanism.
Phillips E; Lang V; Bohlen J; Bethke F; Puccio L; Tichy D; Herold-Mende C; Hielscher T; Lichter P; Goidts V
Int J Cancer; 2016 Oct; 139(8):1776-87. PubMed ID: 27299852
[TBL] [Abstract][Full Text] [Related]
57. Atypical protein kinase C (iota) activates ezrin in the apical domain of intestinal epithelial cells.
Wald FA; Oriolo AS; Mashukova A; Fregien NL; Langshaw AH; Salas PJ
J Cell Sci; 2008 Mar; 121(Pt 5):644-54. PubMed ID: 18270268
[TBL] [Abstract][Full Text] [Related]
58. Metabolism and DNA single strand breaks induced by 4-(methylnitrosamino)-1-(3-pyridyl)-1-butanone and its analogues in primary culture of rat hepatocytes.
Liu LL; Alaoui-Jamali MA; el Alami N; Castonguay A
Cancer Res; 1990 Mar; 50(6):1810-6. PubMed ID: 2306734
[TBL] [Abstract][Full Text] [Related]
59. Targeting the oncogenic protein kinase Ciota signalling pathway for the treatment of cancer.
Fields AP; Frederick LA; Regala RP
Biochem Soc Trans; 2007 Nov; 35(Pt 5):996-1000. PubMed ID: 17956262
[TBL] [Abstract][Full Text] [Related]
60. Nicotine inactivation of the proapoptotic function of Bax through phosphorylation.
Xin M; Deng X
J Biol Chem; 2005 Mar; 280(11):10781-9. PubMed ID: 15642728
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
